The course of C-peptide levels in patients developing diabetes during anti-PD-1 therapy
Introduction: Immune checkpoint inhibitor (ICI) associated diabetes is a harmful adverse event (AE) in patients with cancer following anti-programmed (cell) death protein-1 (PD-1) treatment. There are no available biomarkers able to predict this AE. The primary aim of this study was to investigate C...
Main Authors: | Edwin A. Basak, Karlijn de Joode, Tom J.J. Uyl, Ronald van der Wal, Marco W.J. Schreurs, Sjoerd A.A. van den Berg, Esther Oomen-de Hoop, Cor H. van der Leest, Layal Chaker, Richard A. Feelders, Astrid A.M. van der Veldt, Arjen Joosse, Stijn L.W. Koolen, Joachim G.J.V. Aerts, Ron H.J. Mathijssen, Sander Bins |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332222012288 |
Similar Items
-
Suitability of tumor-associated antibodies as predictive biomarker for response to immune checkpoint inhibitors in patients with melanoma: a short report
by: Ron H J Mathijssen, et al.
Published: (2023-02-01) -
Influence of Genetic Variation in <i>COMT</i> on Cisplatin-Induced Nephrotoxicity in Cancer Patients
by: Bram C. Agema, et al.
Published: (2020-03-01) -
Influence of esomeprazole on the bioavailability of afatinib: A pharmacokinetic cross-over study in patients with non-small cell lung cancer
by: G.D. Marijn Veerman, et al.
Published: (2022-11-01) -
Germline Variation in <i>PDCD1</i> Is Associated with Overall Survival in Patients with Metastatic Melanoma Treated with Anti-PD-1 Monotherapy
by: Mirjam de With, et al.
Published: (2021-03-01) -
Karin Bijsterveld, Mechanical sound. Technology, culture and public problems of noise in the twentieth century
by: Sjoerd van der Wal
Published: (2010-03-01)